Faruk Ustunel

Faruk Ustunel

Auto-generated profile, based on publicly available information

Faruk Ustunel

Affiliations Beykoz Institute of Life Sciences and Biotechnology, Bezmialem Vakıf University, İstanbul, Türkiye Department of Drug Discovery and Development, Institute of Health Sciences, Bezmialem Vakıf University, Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OOOnur Emre Onat
Onur Emre Onat
FUFaruk Ustunel
Faruk Ustunel
CACem Akbostanci
Cem Akbostanci
KDKivilcim E. Doganyigit
Kivilcim E. Doganyigit
MSMerve Sen
Merve Sen
MAMuhittin Cenk Akbostanci
Muhittin Cenk Akbostanci
Essential Tremor (ET) is a common movement disorder characterized by action tremors, primarily affecting the hands and head. lthough previous studies have suggested potential links between ET and aging-related diseases, its relationship with longevity remains unclear, with conflicting evidence in the literature. To investigate this association, we analyzed data from 1,493 individuals across 145 families, encompassing both ET-positive (ET+) and ET-negative (ET−) participants. Using comprehensive statistical methods, including survival function estimation and regression modeling, we examined the potential influence of ET on lifespan. The median age of our participants was 67 years (IQR 54–77). Among deceased individuals, those with ET had a higher median age at death (80 years, IQR 70–86) compared to their ET− counterparts (70 years, IQR 59–77). Living ET+ participants also demonstrated slightly higher median ages (63 years, IQR 53–74) than living ET− individuals (60 years, IQR 49–71). Survival analysis revealed a significantly prolonged lifespan for ET+ individuals compared to ET− individuals (log-rank p = 1.11 × 10 ⁻23). Furthermore, hazard ratio (HR) calculations indicated a reduced risk of mortality for the ET+ group (HR = 0.44, CI95% = 0.37–0.52), particularly among males. These findings suggest that ET may be associated with increased longevity, though the underlying biological mechanisms remain unclear. Further research is essential to elucidate the processes contributing to this relationship and to explore its implications for understanding aging and neurodegenerative disorders.